Total properties:
19
|
|
Serial #:
|
|
Filing Dt:
|
06/21/2010
|
Reg #:
|
|
Reg. Dt:
|
12/13/2011
|
Mark:
|
MIRINFORM
|
|
|
Serial #:
|
|
Filing Dt:
|
06/21/2010
|
Reg #:
|
|
Reg. Dt:
|
12/13/2011
|
Mark:
|
MIRINFORM
|
|
|
Serial #:
|
|
Filing Dt:
|
11/27/2013
|
Reg #:
|
|
Reg. Dt:
|
11/25/2014
|
Mark:
|
INTERPACE DIAGNOSTICS
|
|
|
Serial #:
|
|
Filing Dt:
|
05/23/2014
|
Reg #:
|
|
Reg. Dt:
|
01/05/2016
|
Mark:
|
|
|
|
Serial #:
|
|
Filing Dt:
|
07/01/2014
|
Reg #:
|
|
Reg. Dt:
|
04/28/2015
|
Mark:
|
POWER IN PERFORMANCE
|
|
|
Serial #:
|
|
Filing Dt:
|
08/13/2014
|
Reg #:
|
|
Reg. Dt:
|
04/28/2015
|
Mark:
|
THYGENX
|
|
|
Serial #:
|
|
Filing Dt:
|
08/19/2014
|
Reg #:
|
|
Reg. Dt:
|
08/18/2015
|
Mark:
|
PANCRAGEN
|
|
|
Serial #:
|
|
Filing Dt:
|
08/19/2014
|
Reg #:
|
|
Reg. Dt:
|
01/05/2016
|
Mark:
|
THYRAMIR
|
|
|
Serial #:
|
|
Filing Dt:
|
02/05/2015
|
Reg #:
|
|
Reg. Dt:
|
02/14/2017
|
Mark:
|
BARREGEN
|
|
|
Serial #:
|
|
Filing Dt:
|
02/17/2016
|
Reg #:
|
|
Reg. Dt:
|
05/23/2017
|
Mark:
|
BARREGEN ESOPHAGEAL CANCER RISK CLASSIFIER
|
|
|
Serial #:
|
|
Filing Dt:
|
03/17/2016
|
Reg #:
|
|
Reg. Dt:
|
10/25/2016
|
Mark:
|
|
|
|
Serial #:
|
|
Filing Dt:
|
03/17/2016
|
Reg #:
|
|
Reg. Dt:
|
11/01/2016
|
Mark:
|
INTERPACE DIAGNOSTICS
|
|
|
Serial #:
|
|
Filing Dt:
|
09/21/2016
|
Reg #:
|
|
Reg. Dt:
|
10/24/2017
|
Mark:
|
PANDNA
|
|
|
Serial #:
|
|
Filing Dt:
|
10/16/2017
|
Reg #:
|
|
Reg. Dt:
|
06/26/2018
|
Mark:
|
RESPRIDX
|
|
|
Serial #:
|
|
Filing Dt:
|
04/09/2018
|
Reg #:
|
|
Reg. Dt:
|
01/08/2019
|
Mark:
|
THYGENEXT
|
|
|
Serial #:
|
|
Filing Dt:
|
10/11/2019
|
Reg #:
|
|
Reg. Dt:
|
06/30/2020
|
Mark:
|
INTERPACE BIOSCIENCES
|
|
|
Serial #:
|
|
Filing Dt:
|
11/05/2019
|
Reg #:
|
|
Reg. Dt:
|
06/30/2020
|
Mark:
|
INTERPACE PHARMA SOLUTIONS
|
|
|
Serial #:
|
|
Filing Dt:
|
02/17/2021
|
Reg #:
|
|
Reg. Dt:
|
01/04/2022
|
Mark:
|
INTERPACE BIOSCIENCES
|
|
|
Serial #:
|
|
Filing Dt:
|
02/22/2021
|
Reg #:
|
|
Reg. Dt:
|
03/08/2022
|
Mark:
|
WE OWN OUR FUTURE
|
|